Monograph Details
|
|
Dermatological Disorders
> Psoriasis
|
|
DOVONEX SCALP SOLUTION |
| Manufacturer |
|
Warner Chilcott Laboratories |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Vitamin D3 derivative. |
| Generic Name |
|
Calcipotriene 0.005%; soln; contains isopropanol. |
| Also |
• DOVONEX
• DOVONEX CREAM
|
| Indications |
|
Chronic, moderately-severe psoriasis of the scalp. |
| Children |
|
Not recommended. |
| Adults |
|
Comb hair, apply solution to lesions and rub in. Avoid uninvolved skin. Reevaluate after 8 weeks. |
| Contraindications |
|
Hypercalcemia. Vit. D toxicity. Do not use on face. Scalp soln: acute psoriatic eruptions. |
| Precautions |
|
For dermatologic use only. Avoid mucous membranes. Discontinue if irritation or hypercalcemia occurs (until normocalcemia returns). Elderly. Pregnancy (Cat.C). Nursing mothers. |
| Adverse Reactions |
|
Local irritation, burning/stinging, pruritus, dermatitis, worsening of psoriasis. |
| How Supplied |
Oint, Crm—60g, 120g
Soln—60mL |
|
|
|
|
